RT Journal Article
SR Electronic
T1 The Dawn is Coming —— the Description and Prediction of Omicron SARSCoV-2 Epidemic Outbreak in Shanghai by Mathematical Modeling
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.13.22273788
DO 10.1101/2022.04.13.22273788
A1 Jiang, Minghao
A1 Meng, Guoyu
A1 Wu, Geng
YR 2022
UL http://medrxiv.org/content/early/2022/04/27/2022.04.13.22273788.abstract
AB The COVID-19 Omicron outbreak in Shanghai has been going on for >1 month and 25 million population is subjected to strict lock-down quarantine. Until now, it is not clear how long this epidemic might end. Here, we present a time-delayed differentiation equation model to evaluate and forecast the spreading trend. Our model provides important parameters such as the average quarantine ratio, the detection interval from being infected to being tested positive, and the spreading coefficient to better understand the omicron progression. After data fitting, we concluded on 11 April that the maximum overall number infected in Shanghai would exceed 300,000 on 14 April and the turning point would be in the coming days around 13-15 April, 2022, which is perfectly in line with the real-life infection number. Furthermore, the quarantine ratio in Shanghai was found to be greater than 1, supportive of the effectiveness of the strict lockdown policy. Altogether, our mathematical model helps to define how COVID-19 epidemic progresses under the Shanghai lock-down unprecedented in human history and the Chinese zero tolerance policy.Competing Interest StatementThe authors have declared no competing interest.Funding Statementby research grants 81970132, 81770142, 81800144, 31800642, 82100153 and 82104582 from National Natural Science Foundation of China, a research grant 20JC1410600 from Shanghai Science and Technology Committee, Shanghai Guangci Translational Medical Research Development Foundation, a research grant 20152504 from Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant Support, The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institute of Higher Learning, Samuel Waxman Cancer Research Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors